iSpecimen (ISPC) - Business Payback Period

Corporate emblem and logo of iSpecimen (ISPC)

The market dynamics of iSpecimen Inc. (ISPC) securities demonstrate a P/E ratio of -0.20. The company faces operational losses and inertia among scientists regarding the adoption of digital biomaterial platforms. Simultaneously, the business is developing a cutting-edge IT system for biosample data exchange, integrating AI into marker discovery. Current growth in demand for verified cloud-based samples is bringing the firm closer to the break-even point, a factor already priced in.

iSpecimen Corp (ISPC) Price to Earnings Ratio: for the period 07/04/2022 - 11/11/2026

Comprehensive metric breakdowns and analytics for iSpecimen Inc (ISPC)

- current price and projected stock value:
Share Price iSpecimen Corp|ISPC - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization iSpecimen Inc.|ISPC - Total Company Value
- book capitalization data:
Net Assets per Share iSpecimen|ISPC - Company Book Value|Market Capitalization to Net Assets ispecimen.com|ISPC - Company Total Assets
- company liabilities and liquidity data:
Debt to Capital iSpecimen Inc.|ISPC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio iSpecimen Corp|ISPC - Company Aggregate Debts|Debts to Net Assets iSpecimen Inc.|ISPC - Company Long-Term Debt|Company Current Liabilities iSpecimen|Immediate Liquidity ispecimen.com
- earnings and market multiples details:
ISPC - Company Net Income|Net Profit Forecast iSpecimen Inc.|ISPC - Price to Earnings Ratio|Future Price to Earnings Multiple iSpecimen Corp|ISPC - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio iSpecimen Inc.|ISPC - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months iSpecimen|ISPC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months ispecimen.com|ISPC - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year iSpecimen Inc.
Summary company analysis:iSpecimen Inc.
Original product of iSpecimen Inc.

For iSpecimen Inc. (ISPC), this indicator reflects the market value of the business relative to commission profits derived from pharmaceutical corporations' access to biosamples. By analyzing the company's P/E ratio history, an investor assesses the investment payback period through the ratio of share price to net income, which helps identify asset overvaluation or hidden risks of capital freeze during periods of volatility.

Analysis of competing companies

Price to Earnings Multiple VEEV (veeva.com)|P/E Multiple DOCS|Business Payback Period HealthEquity Inc|Price to Earnings Ratio Waystar Inc. WAY|Business Payback Period CorVel Corp. (CRVL)|PRVA - Price to Earnings Ratio|Market Cap to Net Income HURN|CERT: P/E Multiple|Market Cap to Earnings Omnicell Inc (OMCL)|GDRX (GoodRx Corp) - P/E Multiple|Price to Earnings Ratio Schrodinger Corp (SDGR)|P/E Multiple PHR|Business Payback Period omadahealth.com|Price to Earnings Ratio Evolent Health EVH|HSTM - Price to Earnings Ratio|Definitive Healthcare Inc. - P/E Multiple|Market Cap to Earnings Consensus Corp|Agilon Health (AGL) - Price to Earnings Ratio|Price to Earnings Multiple ABSI|Price to Earnings Ratio SY|NRC: Company Value to Net Income|P/E Multiple SPOK|Business Payback Period OptimizeRx Inc.|Price to Earnings Ratio TruBridge, Inc. TBRG|SLP: Price to Earnings Multiple|SOPHiA GENETICS S.A. - P/E Multiple|Health Catalyst Inc. (HCAT) - Price to Earnings Ratio|CCLD (carecloud.com) - Price to Earnings Ratio|RSSS - Business Payback Period|DLHC (DLH Corp) - P/E Multiple|OneMedNet Corp. (ONMD) - Business Payback Period|Price to Earnings Ratio Scienture (SCNX)|Business Payback Period Healthcare Triangle Inc|Price to Earnings Ratio Bullfrog AI BFRG|WORX (SCWorx Inc) - Market Cap to Net Income|MSP Recovery Inc - P/E Multiple|iCoreConnect Inc. (ICCT) - Price to Earnings Ratio|MEDS: P/E Multiple|ORGS - Business Payback Period|Price to Earnings Ratio RCM|SHCR (Sharecare Inc) - Market Price to Net Income Ratio|Price to Earnings Ratio STRM (Streamline Health Solutions)|SYRA (syrahealth.com) - Company Value to Net Income|Price to Earnings Ratio Apollo Medical Holdings, Inc. AMEH|MODN - Price to Earnings Ratio|NextGen - P/E Multiple